4523 Stock Overview
Engages in the research and development, manufacture, sale, and import and export of pharmaceuticals in Japan.
Snowflake Score | |
---|---|
Valuation | 3/6 |
Future Growth | 3/6 |
Past Performance | 1/6 |
Financial Health | 6/6 |
Dividends | 3/6 |
Eisai Co., Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | JP¥6,628.00 |
52 Week High | JP¥9,614.00 |
52 Week Low | JP¥5,795.00 |
Beta | -0.042 |
11 Month Change | 0.015% |
3 Month Change | 6.22% |
1 Year Change | -26.12% |
33 Year Change | -26.22% |
5 Year Change | 18.23% |
Change since IPO | 306.98% |
Recent News & Updates
Eisai (TSE:4523) Is Due To Pay A Dividend Of ¥80.00
Jul 25Is Eisai (TSE:4523) A Risky Investment?
Jul 11Eisai (TSE:4523) Has Affirmed Its Dividend Of ¥80.00
Jul 11Recent updates
Eisai (TSE:4523) Is Due To Pay A Dividend Of ¥80.00
Jul 25Is Eisai (TSE:4523) A Risky Investment?
Jul 11Eisai (TSE:4523) Has Affirmed Its Dividend Of ¥80.00
Jul 11Eisai Co., Ltd.'s (TSE:4523) P/E Is On The Mark
Jun 10Here's Why Eisai (TSE:4523) Can Manage Its Debt Responsibly
Apr 11Eisai (TSE:4523) Has Affirmed Its Dividend Of ¥80.00
Mar 18Eisai's (TSE:4523) Dividend Will Be ¥80.00
Mar 04Shareholder Returns
4523 | JP Pharmaceuticals | JP Market | |
---|---|---|---|
7D | 0.4% | 0.5% | -5.2% |
1Y | -26.1% | 17.2% | 15.6% |
Return vs Industry: 4523 underperformed the JP Pharmaceuticals industry which returned 15.8% over the past year.
Return vs Market: 4523 underperformed the JP Market which returned 15.7% over the past year.
Price Volatility
4523 volatility | |
---|---|
4523 Average Weekly Movement | 3.9% |
Pharmaceuticals Industry Average Movement | 4.0% |
Market Average Movement | 3.7% |
10% most volatile stocks in JP Market | 7.3% |
10% least volatile stocks in JP Market | 1.8% |
Stable Share Price: 4523 has not had significant price volatility in the past 3 months.
Volatility Over Time: 4523's weekly volatility (4%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1941 | 11,067 | Haruo Naito | www.eisai.co.jp |
Eisai Co., Ltd. engages in the research and development, manufacture, sale, and import and export of pharmaceuticals in Japan. It offers Dayvigo, for the treatment of insomnia; Lenvima, an anticancer agent/molecular targeted medicine for the treatment of thyroid cancer, renal cell carcinoma in combination with everolimus, and hepatocellular carcinoma; Methycobal for the treatment of peripheral neuropathy; and Halaven, an anticancer agent for the treatment of breast cancer. The company also provides Jyseleca, a janus kinase inhibitor; Elental, a branched-chain amino acid preparation; Goofice and Movicol for chronic constipation; Fycompa, an antiepileptic agent; Pariet, a proton-pump inhibitor; Aricept, for Alzheimer's disease/Dementia with Lewy bodies; and Chocola BB plus for the preparation vitamin B2.
Eisai Co., Ltd. Fundamentals Summary
4523 fundamental statistics | |
---|---|
Market cap | JP¥1.89t |
Earnings (TTM) | JP¥42.41b |
Revenue (TTM) | JP¥741.75b |
44.7x
P/E Ratio2.6x
P/S RatioIs 4523 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
4523 income statement (TTM) | |
---|---|
Revenue | JP¥741.75b |
Cost of Revenue | JP¥155.33b |
Gross Profit | JP¥586.42b |
Other Expenses | JP¥544.01b |
Earnings | JP¥42.41b |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Aug 02, 2024
Earnings per share (EPS) | 148.35 |
Gross Margin | 79.06% |
Net Profit Margin | 5.72% |
Debt/Equity Ratio | 17.7% |
How did 4523 perform over the long term?
See historical performance and comparisonDividends
2.4%
Current Dividend Yield108%
Payout RatioDoes 4523 pay a reliable dividends?
See 4523 dividend history and benchmarksEisai dividend dates | |
---|---|
Ex Dividend Date | Sep 27 2024 |
Dividend Pay Date | Nov 18 2024 |
Days until Ex dividend | 61 days |
Days until Dividend pay date | 113 days |
Does 4523 pay a reliable dividends?
See 4523 dividend history and benchmarks